Darzins, A., Kent, N.E., Buckwalter, M.S., and Casadaban, M.C., 1988. Bacteriophage Mu sites required for transposition immunity. Proc Natl Acad Sci USA 85:6826-6830.
Buckwalter, M.S., Katz, R.W., and Camper, S.A., 1991. Localization of the panhypopituitary dwarf mutation (df) on Mouse Chromosome 11 in an intersubspecific backcross. Genomics 10:515-526.
Buckwalter, M.S., Lossie, A.C., Scarlett, L.M., and Camper, S.A., 1992. Localization of the human chromosome 5q genes Gabra-1, Gabrg-2, Il-4, Il-5, and Irf-1 on Mouse Chromosome 11. Mammal Genome 3:604-607.
Lossie, A.C., Buckwalter, M.S., and Camper, S.A., 1993. Lysyl oxidase (Lox) maps between Grl-1 and Adrb-2 on Mouse Chromosome 18. Mamm Genome 4: 177-178.
Buckwalter, M.S., Testa, C.M., Noebels, J.L. and Camper, S.A., 1993. Genetic mapping and evaluation of candidate genes for spasmodic, a neurological mouse mutation with abnormal startle response. Genomics 17:279-286.
Ryan, S.G., Buckwalter, M.S., Lynch, J.W., Handford, C.A., Segurs, L., Shiang, R., Wasmuth, J.J., Camper, S.A., Schofield, P., and O’Connor, P., 1994. A missense mutation in the gene encoding the a1 subunit of the inhibitory glycine receptor in the spasmodic mouse. Nat Genet 7:131-135.
Buckwalter, M.S., Cook, S.A., Davisson, M.T., White, W.F., and Camper, S.A., 1994. A frameshift mutation in the a1 glycine receptor gene (Glra-1) results in progressive neurological symptoms and juvenile death. Hum Mol Genet 3:2025-2030.
Watkins-Chow, D.E., Buckwalter, M.S., Newhouse, M.M., Lossie, A.C., Brinkmeier, M.L., Camper, S.A., 1997. Genetic mapping of 21 genes on mouse chromosome 11 reveals disruptions in linkage conservation with human chromosome 5. Genomics 40:114-122.
Watkins-Chow, D.E., Douglas, K.R., Buckwalter, M.S., Probst, F.J., and Camper, S.A., 1997. Construction of a 3-Mb contig and partial transcript map of the central region of Mouse Chromosome 11. Genomics 45:147-157.
Buckwalter. M.S. , Pepper, J.-P., Gaertner, R.F., Von Euw, D., Lacombe, P., and Wyss-Coray, T., 2002. Molecular and functional dissection of TGF-b1-induced cerebrovascular abnormalities in transgenic mice. Ann NY Acad Sci 977:87-95.
Buckwalter, M.S. and Wyss-Coray, T., 2004. Modelling neuroinflammation in vivo. J Neuroinflammation 1:10.
Buckwalter, M.S., Yamane, M, Coleman, B.S., Ormerod, B.K, Chin, J.T., Palmer, T., and Wyss-Coray, T., 2006. Chronically increased Transforming Growth Factor-b1 strongly inhibits hippocampal neurogenesis in aged mice. American Journal of Pathology 169: 154-164.
Buckwalter, M.S., Coleman, B.S., Buttini, M., Barbour, R., Schenk, D., Games, D., Seubert, P., and Wyss-Coray, T., 2006. Increased T cell recruitment to the CNS after amyloid b1-42 immunization in Alzheimer’s mice overproducing Transforming Growth Factor-b1. J. Neuroscience, 26: 11437-11441.
Luo, J., Ho, P.P., Buckwalter, M.S., Hsu, T., Lee, L.Y., Zhang, H., Kim, D.-K., Kim, S.-J., Gambhir, S.S., Steinman, L.J., and Wyss-Coray, T. 2007. Glia-dependent TGF-b signaling, independent of the TH17 pathway, characterizes a brain-immune interaction critical for initiation of autoimmune encephalitis. JCI 117(11):3306-3315.
